MSB 3.36% $1.15 mesoblast limited

Ann: Mesoblast Update on COVID-19 ARDS Trial, page-165

  1. 1,047 Posts.
    lightbulb Created with Sketch. 168
    one more fail and it is a 10 cent stock. I personally feel that there is some value in their patents and IP. Maybe after another fail result, Novartis will buy them out for nothing. The only losers are the real investors that have poured more than a billion dollars supporting this company.
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.15
Change
-0.040(3.36%)
Mkt cap ! $1.370B
Open High Low Value Volume
$1.18 $1.22 $1.15 $3.612M 3.050M

Buyers (Bids)

No. Vol. Price($)
3 12289 $1.15
 

Sellers (Offers)

Price($) Vol. No.
$1.16 154752 8
View Market Depth
Last trade - 12.37pm 15/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.